Dr. Sulaiman Al Habib Medical Services Group
4013 · TASI — Main Market · 2026-07-29
Download report (PDF)
Snapshot Price 218.70 SAR
Market cap 76.55B SAR
P/E 31.87×
P/B 9.69×
ROE 30.39%
Dividend yield 2.17%
Revenue CAGR 18.15%
Valuation (Hajras) Fair value 64.53 SAR
Rating overvalued
Upside/(downside) -70.49%
DCF 60.82
DDM 70.75
Graham 58.67
Discount rate 9.92%
DCF growth 8.00%
Financials SAR FY22 FY23 FY24 FY25 Revenue 8.31B 9.51B 11.20B 13.71B Net income 1.65B 2.05B 2.32B 2.40B EPS 4.72 5.85 6.62 6.86 DPS 3.25 4.10 4.69 4.75 Equity 5.88B 6.49B 7.18B 7.90B
Analyst Price Targets Consensus (median) — SAR
Range — – — SAR
Aljazira Capital (hold) 193.00 SAR
This report is for informational purposes only and is not investment advice. Sources: Hajras valuation & financials, Yahoo/SEC EDGAR, and investment-house targets.